Angiogenesis has emerged as a critical process for tumour progression. Identifying key pathways involved in the regulation and promotion of angiogenesis has resulted in the development of numerous approaches targeting pro-angiogenic signalling pathways. The most prominent and characterised pro-angiogenic pathway is the vascular endothelial growth factor signalling pathway. This review will describe several inhibitors of angiogenesis currently in clinical trial and their various targets. Targe...Expand abstract
- Publisher copy:
- Copyright date:
The angiogenic process as a therapeutic target in cancer.
If you are the owner of this record, you can report an update to it here: Report update to this record